简化乳腺MRI(FAST MRI)作为乳腺癌筛查工具的潜在效用:系统综述与Meta分析
该系统综述与Meta分析纳入5项研究(6篇文章),共2763名女性、3251个筛查轮次,比较简化乳腺MRI(abMRI)与全方案MRI(fpMRI)在乳腺癌筛查中的准确性。GRADE证据等级为极低。以fpMRI(阳性者结合组织学)为参考标准,abMRI总体敏感度为94.8%(95%CI 85.5-98.2),特异度为94.6%(95%CI 91.5-96.6)。3项研究(1450名女性、1613个筛查轮次)的随访数据显示,abMRI与fpMRI的敏感度和特异度无显著差异(P=0.83和P=0.37)。极低级别证据提示abMRI可能对乳腺癌筛查具有准确性,但需进一步研究随访间期癌以确定其对临床结局的影响。
要点
- abMRI以fpMRI(阳性者结合组织学)为参考标准,敏感度94.8%(95%CI 85.5-98.2),特异度94.6%(95%CI 91.5-96.6)。
- 3项研究(1450名女性、1613个筛查轮次)显示abMRI与fpMRI的敏感度和特异度无显著差异(P=0.83和P=0.37)。
- GRADE评估证据等级为极低,因参考标准判读时知晓指数试验结果且并非所有abMRI阳性者均获得活检。
核心结论
- 极低级别证据提示abMRI可能对乳腺癌筛查具有准确性。
- 需开展随访至间期癌的研究,以确定abMRI的使用对临床结局可能产生的影响。
研究设计与样本
- 系统综述与Meta分析,系统检索多个数据库。
- 纳入标准:非富集队列研究,提供abMRI在筛查中的准确性数据,涵盖任何风险水平(人群、中等风险、高风险)。
- 共纳入5项研究(6篇文章),合计2763名女性、3251个筛查轮次。
- 证据等级采用GRADE评估,结果为极低。
- Meta分析采用双变量随机效应模型,以fpMRI及fpMRI阳性病例的组织学为参考标准,并将随访至症状性检出追加至fpMRI。
诊断标准与关键数值
- abMRI以fpMRI(阳性者结合组织学)为参考标准,总体敏感度94.8%(95%CI 85.5-98.2),特异度94.6%(95%CI 91.5-96.6)。
- 3项研究(1450名女性、1613个筛查轮次)提供随访数据,abMRI与fpMRI的敏感度比较P=0.83,特异度比较P=0.37,均无显著差异。
- GRADE证据等级为极低,原因包括参考标准判读时知晓指数试验结果,且并非所有abMRI阳性者均获得活检。
临床应用与阅片要点
- 原文结论指出极低级别证据提示abMRI可能对乳腺癌筛查具有准确性,需进一步研究随访间期癌以确定其对临床结局的影响。
- 原文未据此给出具体阅片或报告推荐。
局限性
- GRADE评估证据等级为极低,因参考标准判读时知晓指数试验结果且并非所有abMRI阳性者均获得活检。
- 需开展随访至间期癌的研究,以确定abMRI的使用对临床结局可能产生的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
AIM: To synthesise evidence comparing abbreviated breast magnetic resonance imaging (abMRI) to full-protocol MRI (fpMRI) in breast cancer screening.
MATERIALS AND METHODS: A systematic search was undertaken in multiple databases. Cohort studies without enrichment, presenting accuracy data of abMRI in screening, for any level of risk (population, moderate, high risk) were included. Level of evidence was assessed using the Grading of Recommendations Assessment, Development and Evaluation (GRADE). Meta-analyses (bivariate random effects model) were performed for abMRI, with fpMRI and histology from fpMRI-positive cases as reference standard, and with follow-up to symptomatic detection added to the fpMRI. The review also covers evidence comparing abMRI with mammographic techniques.
RESULTS: The title and abstract review retrieved 23 articles. Five studies (six articles) were included (2,763 women, 3,251 screening rounds). GRADE assessment of the evidence was very low because the reference standard was interpreted with knowledge of the index test and biopsy was not obtained for all abMRI positives. The overall sensitivity for abMRI, with fpMRI (and histology for fpMRI positives) as reference standard, was 94.8% (95% confidence interval [CI] 85.5-98.2) and specificity as 94.6% (95% CI: 91.5-96.6). Three studies (1,450 women, 1,613 screening rounds) presented follow-up data, enabling comparison between abMRI and fpMRI. Sensitivities and specificities for abMRI did not differ significantly from those for fpMRI (p=0.83 and p=0.37, respectively).
CONCLUSION: A very low level of evidence suggests abMRI could be accurate for breast cancer screening. Research is required, with follow-up to interval cancer, to determine the effect its use could have on clinical outcome.
引用
- Geach R, Jones LI, Harding SA, et al. The potential utility of abbreviated breast MRI (FAST MRI) as a tool for breast cancer screening: a systematic review and meta-analysis. Clin Radiol. 2020. PMID: 33010932. doi:10.1016/j.crad.2020.08.032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。